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Recent biochemical studies have identiﬁed a cell surface receptor for thyroid and steroid hormones that bind near the
arginine-glycine-aspartate (RGD) recognition site on the heterodimeric αvβ3 integrin. To further characterize the intermolecular
interactions for a series of hormone analogues, combined quantum mechanical and molecular mechanical (QM/MM) methods
were used to calculate their interaction energies. All calculations were performed in the presence of either calcium (Ca2+)o r
magnesium (Mg2+) ions. These data reveal that 3,5 -triiodothyronine (T3) and 3,5,3 ,5 -tetraiodothyroacetic acid (T4ac) bound
in two diﬀerent modes, occupying two alternate sites, one of which is along the Arg side chain of the RGD cyclic peptide site.
These orientations diﬀer from those of the other ligands whose alternate binding modes placed the ligands deeper within the RGD
binding pocket. These observations are consistent with biological data that indicate the presence of two discrete binding sites that
control distinct downstream signal transduction pathways for T3.
1.Introduction
Integrins are plasma membrane proteins that generate com-
plex and intracellular signals during morphogenesis, tissue
remodeling, and repair [1]. Interactions of integrins with
speciﬁc extracellular matrix proteins and growth factors or
with certain small molecules generate ligand-speciﬁc signals.
The integrin superfamily of heterodimeric glycoproteins
consists of α-a n dβ-monomers that associate in deﬁned
combinations that include more than twenty diﬀerent mam-
malian subtypes, of which at least eight are characterized
by the presence of an Arg-Gly-Asp (RGD) site used in the
process of recognition of diﬀerent protein ligands [1–3]. The
combination of αvβ3 subunits is the most abundant integrin
expressed in mammalian cells [1].
Structural data have revealed that the extracellular seg-
ment of integrin αvβ3 (i.e., lacking the transmembrane and
cytoplasmic tails) is V shaped with the 4-domain αv subunit
and the 8-domain β3 subunit bent by 135◦ [4–6]. Data for
the RGD cyclic pentapeptide complex reveals that the RGD
peptide occupies a shallow crevice between the propeller and
βA domains in the integrin head.
The X-ray structure of apo αvβ3 has been determined in
the presence of Ca2+ ions [6] and in the presence of Mn2+
as a complex with the cyclic pentapeptide Arg-Gly-Asp-{D-
Phe}-{N-methyl-Val} (Figure 1)[ 4]. These data showed that
replacement of Ca2+ with Mn2+ in the αvβ3 integrin did not
result in any important structural changes to the protein.
There are also relatively small changes in the αvβ3s t r u c t u r e
with and without the cyclic pentapeptide bound in the RGD
site of integrin.
Ligand binding to integrins is dependent upon bivalent-
cation interactions that are generally stimulated by Mg2+
or Mn2+ and inhibited by Ca2+. Competitive binding data2 Journal of Biomedicine and Biotechnology
Figure 1: View of αvβ3 integrin from 1L5G.pdb (Xiong et al.,
2001 [4]). RGD cyclic pentapeptide is shown as space ﬁlling atoms
(violet), NAG sugars are stick ﬁgures in various colors, and the
sphere (purple) is a Mn2+ ion. The αv domain is green and the β3
domain is cyan. Figure drawn with PyMol.
revealed preferential binding sites for one or more cations
that could also be displaced by other cations and that their
speciﬁc occupancy can lead to enhanced ligand binding in
an allosteric or synergistic manner [1, 7]. The central core of
the β-propeller is one of the primary sites for cation binding.
A common structural motif observed for integrins is the
presenceofametalbindingsite,termedmetalion-dependent
adhesion site (MIDAS), that is unique for Mg2+/Mn2+ and is
located in the integrin α subunit I domain. Mutagenesis data
have shown that the MIDAS motif and the nearby solvent
exposed side chains are required for ligand binding [3].
The integrin protein family has been studied both
experimentally and theoretically [8–15]. Studies using NMR
and molecular dynamics methods to map the interaction
of the cyclic β-peptide isoDGR, a competitive antagonist
of RGD-containing ligands of αvβ3 integrin that inhibits
endothelial cell adhesion, proliferation, and tumor growth,
revealed a new recognition motif of the RGD binding pocket
of αvβ3 integrin [9]. Docking studies for a series of cyclic
peptides further deﬁned the structure-function relationships
in binding to the RGD recognition site of αvβ3 integrin.
Studies using a combination of experimental and com-
putational approaches deﬁned the role of divalent cations
in mediating the binding of integrins to RGD peptides.
Structural data revealed that the divalent cation at the
M I D A Ss i t ei nt h eβA domain of integrin contacts the Asp
of the RGD peptide. This site is occupied by the divalent
ion only in the RGD-liganded state [15]. The results of
these molecular dynamics studies support the stability of
the orientation of Asp residue of the RGD recognition site
that interacts with the MIDAS which is essential for binding,
whereas the orientation of Glu220 carboxyl oxygens of the
β3 domain for the ligand associated metal binding sites
(LIMBSs)wasmaintainedthroughoutthemoleculardynam-
ics simulations [10, 15]. The steered molecular dynamics
studies of the unbinding of RGD cyclic peptides from αvβ3
integrin revealed the importance of single water molecules
tightly coordinated to the MIDAS ion. These data suggest
that this process is a general strategy for the stabilization of
protein-protein adhesion against cell-derived forces through
divalent cations [15].
Recently, a cell surface receptor for thyroid hormone
has been identiﬁed on the extracellular domain of the αvβ3
integrin [16] that is relevant to the proliferative [16–19]
and proangiogenic activity of thyroid hormone [16, 20, 21].
Transduction of the hormone signal into proliferation and
angiogenesis at the integrin is achieved by the mitogen-
activated protein kinase (MAPK; extracellular regulated
kinase 1/2, ERK1/2) pathway [16, 19, 22, 23] or by the
phosphatidylinositol 3-kinase (P3K)/Akt pathway [24–26].
L-Thyroxine (T4) and 3,5,3 -triiodo-L-thyronine (T3)a r e
agonist thyroid hormone analogues at the integrin receptor,
whereas a deaminated derivative of T4, tetraiodothyroacetic
acid (T4ac), is a nonagonist inhibitor of the binding of T4
and T3 to integrin. Competition data revealed that RGD
peptides also block hormone binding by integrin, suggesting
that the hormone-binding site is near the RGD recognition
site on αvβ3. Further analysis revealed that RGD peptides
could inhibit the binding of other biologically active small
molecules with estrogen-like structures, such as cis- and
trans-resveratrol and stilbene (Figure 2)[ 18, 27–29]. These
data reveal that T4 promotes cell proliferation in cancer
cells whereas resveratrol is proapoptotic and that further
shows that T4 inhibits resveratrol-induced apoptosis [18].
This action is prevented by T4ac, shown to be an inhibitor
of T4 binding to integrin. In the presence of T4,T 4ac does
not aﬀect the induction of apoptosis by resveratrol [18, 30].
Theseobservationssuggestthatthereisadiscretebindingsite
for resveratrol and thyroid hormone on integrin.
The noniodinated thyroid hormone analogue GC-1 lacks
the amino group of the alanine side chain, lacks the ether
linkage between phenyl rings, and has methyl groups at
the 3,5-positions and an isopropyl group at the 3 -position,
compared with the thyroid hormone T3 (Figure 2). This
thyroid hormone analogue is a selective agonist for nuclear
thyroid hormone receptor TRβ1 and has the desirable
metabolic eﬀect of lowering circulating cholesterol without
inducing tachycardia [31, 32]. GC-1 was also demonstrated
to be proangiogenic at the plasma membrane and require
interaction with αvβ3 integrin [20].
To understand how these hormones and their analogues
interact with integrin, modeling studies were carried out
using the coordinates of the extracellular fragment of αvβ3
integrin (1L5G.pdb) [4, 5] as a starting model for their
interactions near the RGD recognition site [27]. These
preliminary models revealed that the hormone analogues
shown in Figure 2 can bind in the RGD recognition site and
that there may be two closely related binding pockets that
can bind these hormone analogues. The smaller of these sites
may be preferential for the more planar compounds such as
estradiol, stilbene, or resveratrol.Journal of Biomedicine and Biotechnology 3
HO
I
I
I
I
O
O
O
N
T4
(a)
HO
I I
I
O
O
O
N
T3
(b)
HO
I
I
I
I
O
O
O
T4Ac
(c)
HO
O O
O
O
GC-1
(d)
HO
OH
E2 estradiol
(e)
Trans-Stilbene
(f)
Cis-Stilbene
(g)
HO
OH
OH
Trans-Resveratrol
(h)
HO
OH
OH
Cis-Resveratrol
(i)
Figure 2: Schematic of ligands bound to αvβ3 integrin.
2.MaterialandMethods
To provide more deﬁnitive details of the intermolecular
interactions of these hormone analogues with the RGD
recognition site in αvβ3 integrin, quantitative molecular
modeling including molecular dynamics (MD) simulations
andcombinedquantummechanical—molecularmechanical
(QM/MM) methods were employed. These calculations also
incorporated the eﬀects of solvent and divalent cations on
ligand-binding interactions. In order to calculate the desol-
vation energies of these ligands, an explicit water environ-
ment based on molecular dynamics (MD) simulations was
used in the QM/MM calculations.
In the present study we utilized our own method of
combined QM/MM calculations which are based on MD.
In this approach, standard MD of the protein solvated by
a sphere of explicit water molecules was carried out. Then
a randomly chosen set of snapshots was selected from the
MD,andforeachsnapshot,fullgeometryoptimizationofthe
ligand (QM) in a ﬁxed protein matrix (MM) was performed.
In order to calculate the desolvation energy of the ligand, the
same QM/MM was used to calculate the ligand surrounded
by a sphere of explicit water molecules. The ligand-binding
energy to the protein was calculated as a diﬀerence between
the average ligand energy in the protein and the water
environment. These computations were performed using the
quantum-chemical program Q-Chem [33], which includes
a modiﬁed version of an interface between QM and MM
atoms [34]. Since the combined QM/MM calculations for
each snapshot are independent of the other snapshots, this
method referred to as the large-scale QM/MM method has
the advantage of perfect parallel scalability [35]. All calcula-
tions were performed using a large 1.000 node Linus cluster
where each node consists of two 3.2GHz Xeon processors
a n d2G Bo fs h a r e dm e m o r y .
3. Computational Details
Coordinates from the X-ray structure of the αvβ3r e c e p t o r
(1L5G PDB) were used as a starting model [4]. The
cyclic RGD pentapeptide was removed from the ﬁle and
original Mn2+ ions were replaced by Mg2+ or Ca2+ ions.
Parameters of the NAG residues observed in this structure
were obtained from the ANTECHAMBER program of
the AMBER programming suite [36]. All hydrogen atom
positions were populated based on the AMBER force ﬁeld.
A total of 25 Na+ cations were used to neutralize the entire
protein. The positions of these cations were obtained from
grid calculations of the protein electrostatic potential [37,
38]. The ligand structures (Figure 2) were obtained using
quantum mechanical (QM) calculations at the B3LYP/6-
31+G∗ level of theory. The QM calculations consisted of
full geometry optimization of the ligands performed in the
gas phase. These calculations, including iodine atoms of the
thyroid hormones (T4,T 3,T 4ac), were obtained using the
lanl2dz eﬀectivecore potential witha corresponding basis set
[38].
Docking calculations were carried out using the Auto
Dock 3 program [39]. Because of the lack of molecular
mechanicalparametersforiodineintheAutoDockprogram,
this atom was temporary replaced in the docking process by
a carbon atom. The docking procedure was performed using
a ﬁxed internal geometry of these ligands. After docking,
one snapshot of these compounds was randomly selected for
subsequent study. The precise selection of a docked structure
is not important because geometry and orientation of the
molecule inside the protein active site were recalculated
in the following MD simulations and in the QM/MM
calculations. Once these ligands were docked to the protein
near the RGD recognition site of αvβ3 integrin, another
round of MD simulations was carried out. Parameters of the4 Journal of Biomedicine and Biotechnology
ligands were obtained using the ANTECHAMBER program
in the AMBER suite.
The molecular system, including the protein, the ligand,
and the metal ions, was placed into a center of TIP3P
water sphere of radius 80 ˚ A. The MD consisted of 100ps
heating dynamics from 0 to 300K, followed by equilibration
dynamics performed for 5ns. The MD simulation was also
performed at constant temperature and volume, with appli-
cation of constrained harmonic potentials outside the water
sphere and for the metal ions. The MD has been performed
separately for each ligand (Figure 2) and separately for the
protein system with Ca2+ and Mg2+ ions. Following the
MD simulations, combined QM/MM calculations of the
interaction between the ligand and the protein environment
were carried out. First, a randomly selected protein snapshot
from MD was chosen that was then divided into QM part
and MM contributions. The QM part included the ligand
and the MM part included the rest of the protein system with
water molecules and the metal ions. Finally, full geometry
optimization of the QM part inside the ﬁxed positions of all
atoms of the MM part was performed using the B3LYP/6-
31+G∗/AMBER method [34], as implemented in the Q-
Chem program [33]. During geometry optimization, the
ligands were allowed to change their internal geometry and
position relative to the ﬁxed protein matrix. The calculations
of the ligands, including those with iodine atoms (T4,
T3,T 4ac), were performed using the lanl2dz eﬀective core
potential with a corresponding basis set.
The interaction energy between the ligand and the
protein was calculated as an energy diﬀerence between the
energy of the molecule inside the protein and the energy of
the molecule in the gas phase which was obtained from the
optimal geometry of the molecule in the protein and in the
gas phase, respectively. The same procedure was then applied
to 600 randomly selected protein snapshots from the last
200ps of MD, and the results of the calculations are reported
statistically based on the selected protein ensemble (Tables 1
and 2).
Calculations of an induced dipole moment of the ligands
(Figure 2) bound to the protein and in water were also car-
ried out (Table 2). The induced dipole moment is reported
as a diﬀerence between the permanent dipole moment of
the ligand in the protein (water) and the permanent dipole
moment of the ligand in the gas phase, obtained from the
optimal geometry of this molecule in the protein (water)
and the gas phase, respectively. The calculated values of
the interaction energies and induced dipole moments are
reported as average values based on an ensemble of 600
protein (solvent) samples. Use of a larger number of samples
in the ensemble would represent the protein (solvent) system
much more realistically; however it requires more time-
consuming calculations. Therefore the number of samples
(snapshots) chosen in the calculations was a compromise
between computational accuracy and eﬃciency.
4. Results andDiscussion
4.1. Computational Models of Ligand Interactions. Structural
data for the extracellular portion of αvβ3 integrin reveals
Table 1: The interaction energy between the ligands (Figure 2)
and the protein (or water). Numbers in parenthesis indicate the
interaction energy of the ligand bound in the protein relative to
the interaction energy of this molecule in water. The interaction
energy is calculated as a diﬀerence between the energy of the ligand
bound in the protein (or water) and the energy of this molecule in
the gas phase, for the optimal geometry of this molecule bound in
the protein (water) and the gas phase, respectively.
Ligands
Interaction energy (kcal/mol)
Protein
Water
Mg2+ Ca2+
cis-Resveratrol −49 (−6) −63 (−19) −44
trans-Resveratrol −59 (−14) −65 (−20) −45
cis-Stilbene −48 (−19) −53 (−24) −29
trans-Stilbene −45 (−12) −48 (−20) −32
Estradiol −124 (−72) −60 (−8) −52
GC-1 −77 (−13) −96 (−33) −63
T3 −109 (−60) −84 (−35) −49
T4 −75 (−27) −62 (−14) −48
T4ac −60 (−15) −59 (−14) −44
Table 2: The induced dipole moment of the ligands (Figure 2)
bound in the protein (water). Numbers in parenthesis indicate
the induced dipole moment of the ligand in the protein relative
to the induced dipole moment of this molecule in water. The
induced dipole moment is calculated as a diﬀerence between the
permanent dipole moment of the ligand in the protein (water) and
the permanent dipole moment of this molecule in the gas phase, for
the optimal geometry of this molecule in the protein (water) and
the gas phase, respectively.
Ligands
Induced dipole moment (debye)
Protein
Water
Mg2+ Ca2+
cis-Resveratrol 1.4 (0.1) 2.6 (1.3) 1.3
trans-Resveratrol 3.4 (1.2) 4.4 (2.3) 2.1
cis-Stilbene 1.8 (1.0) 1.8 (1.0) 0.8
trans-Stilbene 2.3 (1.3) 1.5 (0.5) 1.0
Estradiol 6.2 (3.8) 1.1 (−1.3) 2.4
GC-1 5.2 (2.3) 3.6 (0.6) 2.9
T3 3.1 (0.2) 5.5 (2.6) 2.9
T4 5.2 (3.8) 1.3 (−0.2) 1.4
T4ac 2.5 (2.5) 1.5 (1.4) 0.1
a heterodimer with 12 domains assembled into an ovoid
“head”andtwo“tails.”TheαvandβAdomainsformaseven-
bladed propeller and the β3 portion of the integrin “head” is
composed of the βA and hybrid domains (Figure 1)[ 4, 5].
The RGD cyclic peptide containing the RGD sequence binds
in a crevice between the propeller and the βA domains of the
integrin head (Figure 1)[ 5]. These data reveal interactions
of the RGD peptide Asp with the backbone of Tyr122 and
Asn215 and the side chain atoms of Arg214 of the β3d o m a i n
of αvβ3 integrin and the Arg of RGD interacts with Asp150
and Asp218 of the αvd o m a i n( Figure 3). Also illustrated inJournal of Biomedicine and Biotechnology 5
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Figure 3: Crystal structure of αvβ3 integrin (yellow/violet) with
RGD cyclic peptide (cyan) (1I5g.pdb) with T4Ac (red) and estradiol
(E2, yellow) modeled into the RGD binding pocket. Residues
Asp150andAsp218intheαvdomainandTyr122andAsn215inthe
β3 domain are labeled for orientation. Figure drawn with PyMol.
Figure 3isthebindingorientationofT4ac(red)andestradiol
(yellow) as docked in the RGD cyclic peptide binding pocket.
Only small conformational changes were noted near the βA
domain between the apo integrin structure and the RGD
cyclic peptide complex [5]. These changes are also involved
the metal (Ca2+ or Mn2+) binding site in this region.
To model thyroid or steroid hormone analogue interac-
tions near the RGD cyclic peptide binding site, molecular
docking experiments using quantum chemical calculations
(QM/MM) were carried out in the presence of Ca2+ or Mg2+
for each of the ligands shown in Figure 2. Furthermore, these
calculations were carried out with the ligand in two diﬀerent
starting positions near the RGD binding site (indicated as
Ca1andCa2)toremovemodelingbiasfromthecalculations.
Similar calculations were made with the ligand starting
position about 15 ˚ A away from the RGD binding site. The
results of the distant starting site calculations showed much
smaller stabilization energies and suggest that the interaction
between the ligand and metal cations is an important
part of ligand binding (data not shown). The results of
these quantitative calculations are compared with previously
reported qualitative docking studies [27].
4.2. Thyroid Hormone Binding. The results of the QM/MM
modeling for the thyroid hormones, T4,T 3,a n dT 4ac, based
on two starting orientations near the RGD binding site
at the interface of the αva n dβ3 domains, show that the
thyroid hormones can bind in a wide range of orientations.
In the case of T4, the diﬀerent starting positions result
in binding modes in which the amino and hydroxyl ends
of the molecule are ﬂipped in the binding pocket. In one
orientation, the 4 -hydroxyphenyl ring occupies a binding
pocket deeper within the crevice between the αvβ3 domains,
while in the other binding mode, the phenolic ring occupies
the interface between the integrin αvβ3 domains (Figure 4).
Consistentwithpharmacokinetic/pharmacodynamicmodel-
ing reported elsewhere [26], the QM/MM modeling results
for T3 diﬀer signiﬁcantly from those of T4 (Figure 5). In
one mode, the tyrosyl moiety lies along the Arg side chain
of the cyclic RGD peptide (Figure 6). The second binding
mode for T3 places the 4 -phenolic ring in a diﬀerent
binding pocket than observed for T4 (Figure 5). The results
for the two starting positions of T4ac reveal yet another
variation in binding modes (Figure 7). In this case, one of
the T4ac orientations aligns along the side chain of Arg in
the RGD peptide binding site, as was observed for one of
the orientations of T3 (Figure 6). Comparison of the other
starting position for T3 and T4ac reveals a binding mode in
whichthephenolicringofT4acbindsdeeperwithintheRGD
binding pocket, similar to that of T4. The phenolic ring of
T3 occupies an alternate pocket not occupied by either T4
or T4ac (Figure 8). The one starting position calculated for
the noniodinated thyroid analogue GC-1 binds in a similar
manner to that of T3 (Ca2) (Figure 9).
Thediﬀerences in binding modes possible for the thyroid
hormones are in agreement with competition data that
indicate that RGD peptides block hormone binding by αvβ3
integrin.ThesestudiesfurthershowthatT4acisanonagonist
inhibitor of T4 and T3 binding to αvβ3 integrin.
4.3. Steroid-Like Ligands. The results of the QM/MM mod-
eling of ligand interactions with cis- and trans-reservatrol
based upon two starting positions show that these ligands
have similar binding orientations near the RGD binding site
(Figure 10). In the case of the cis-resveratrol, both starting
positions placed the ligand in similar orientations such that
the dihydroxyphenyl ring makes interactions with Asn215
of the β3 domain. In the case of trans-resveratrol, the
two starting positions result in the molecule being ﬂipped
such that the dihydroxyphenyl ring is bound the opposite
direction. The 4 -hydroxyphenyl ring still maintains contact
to Asn215 of the β3d o m a i n( Figure 10). These results are
in agreement with biochemical data that indicate only the
β3 monomer was essential for activation and induction
of apoptosis by resveratrol and that the occlusion of the
RGD binding site blocks the cellular actions of resveratrol
[30].
The modeling results for the QM/MM binding modes
of cis-a n dtrans-stilbene, the nonhydroxylated parent com-
pound of resveratrol, revealed that the energy minimum
conformation for the two starting positions of cis-stilbene
were perpendicular to each other with one conformer bound
deeper in the binding pocket than the other cis-conformer
(Figure 11). The results for the two starting positions of
trans-stilbene show one molecule bound deeper in the
RGD pocket than the other which is outside the binding
pocket. The more hydrophobic nature of cis-a n dtrans-
stilbene compared with cis-a n dtrans-resveratrol results in
thegreatervariabilityofitsbindingmodesasthesemolecules
donotoptimizebindinginvolvingspeciﬁchydrogenbonding
interactions with residues in the RGD binding site.
The binding data for estradiol show that the 3-hydroxyl
can interact with Asn215, as observed for resveratrol. An
alternate orientation for estradiol binding shows the mole-
cule perpendicular to that of the ﬁrst and ﬁlling an alternate
binding site (Figure 12).6 Journal of Biomedicine and Biotechnology
−100.217 100.217 −100.217 100.217
Figure 4: Stereoview of QM/MM model for T4 (green, Ca1) and T4 (cyan, Ca2) bound in αvβ3 integrin at the RGD binding site. Note
that this energy minimum conformation has T4 bound in a “forward” and “reverse” orientation with the phenolic ring ﬂipped in opposite
directions. The electrostatic surface for integrin is shown. Red is negative and blue is positive surface. αv domain is green and β3d o m a i ni s
cyan. Figure drawn with PyMol.
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Figure 5: Stereoview of QM/MM model for T3 bound in αvβ3 integrin at the RGD binding site. T3 bound in two orientations: one
orientation (yellow, Ca1) has the phenolic ring binding in a diﬀe r e n tp o c k e tt h a nt h a to fT 4 while the other orientation of T3 (blue, Ca2)
binds in a mode that is perpendicular to the ﬁrst.
4.4. Computational Models. The interaction energies be-
tween thyroid hormone analogues and the RGD recognition
site of αvβ3 integrin are presented in Table 1 that also shows
the interaction energies between these ligands and water. As
illustratedinTable 1,allcalculatedinteractionenergiesinthe
proteinaremorenegativethanthecorrespondinginteraction
energies of those molecules in the water environment, which
indicates that these molecules are more strongly stabilized
by the protein environment than by the water environ-
ment. Among these ligands, estradiol shows the strongest
interaction energy with the protein containing Mg2+ ions,
namely, −72kcal/mol, while GC-1 shows the strongest
interaction energy with the protein containing Ca2+,n a m e l y ,
−33kcal/mol. Both values of the interaction energy include
the calculated desolvation energies obtained in this study.
T3 shows a relatively strong interaction with the αvβ3
integrin and the type of metal binding present; namely, the
interaction energy with the protein containing the Mg2+
ions has a value of −60kcal/mol, and the interaction energy
with the protein containing the Ca2+ ions has a value ofJournal of Biomedicine and Biotechnology 7
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Figure 6: Stereoview of QM/MM model for T3 (blue-Ca2) and T4ac (beige) bound in αvβ3 integrin at the RGD peptapeptide (violet)
binding site. The electrostatic surface for integrin is shown. Red is negative and blue is positive surface. αv domain is green and β3d o m a i n
is cyan. Spheres (purple/violet) are Ca2+/Mg2+. Figure drawn with PyMol.
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Figure 7: Stereoview of QM/MM model for T4ac bound in αvβ3 integrin at the RGD binding site. T4ac bound in two orientations: one
orientation (green, Ca1) has the phenolic ring binding in a diﬀe r e n tp o c k e tt h a nt h a to fT 4 while the other orientation of T3 (beige, Ca2)
binds in a mode that is perpendicular to the ﬁrst.
−35kcal/mol.Similarly,bothvaluesoftheinteractionenergy
include the calculated desolvation energies obtained in this
study.
It is interesting to note that the interaction energy of
T3 with the protein containing both divalent metal ions is
larger than the interaction energy of T4, even though both
compounds have similar interaction energies with water.
This observation indicates that an additional iodine atom in
T4 actually decreases its interaction energy with the protein.
Moreover, the interaction energy of T4 is larger than the
interaction energy of T4ac indicating that the NH2-group
which is present in T4 and is absent in T4ac increases the
interactionenergybetweentheligandandprotein.Generally,
the protein environment with the Ca2+ ions stabilizes ligands
such as resveratrol and stilbene, stronger than the protein
environment with the Mg2+ ions. However, for the other
ligands studied the protein environment with Mg2+ stabilizes
the ligand more strongly than the protein environment
with Ca2+.R e s v e r a t r o la n ds t i l b e n eb o t hh a v el e s sﬂ e x i b l e
geometries, where internal rotations around the single C–C
bonds between phenyl rings and a C=Cd o u b l eb o n d
are constrained by steric interactions of phenyl hydrogen
atoms.Lessﬂexible geometriespreventthosemoleculesfrom
penetrating deeper into the protein active site and keeps
them constrained on the surface of the binding pocket. The
other ligands show much more ﬂexible geometries, giving8 Journal of Biomedicine and Biotechnology
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Figure 8: Stereoview of QM/MM model for T3 (gold, Ca2), T4ac (beige, Ca1), and T4 (green, Ca1) bound in αvβ3 integrin at the RGD
binding site. The electrostatic surface for integrin is shown. Red is negative and blue is positive surface. αv domain is green and β3d o m a i n
is cyan. Figure drawn with PyMol.
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Figure 9: Stereoview of αvβ3 integrin RGD electrostatic surface showing GC-1 (violet) and T3 (gold, Ca2) near the RGD binding site.
greater opportunity to penetrate deeper into the protein
active site. Deeper penetration of the protein active site by
estradiol, GC-1, T3,T 4,a n dT 4ac, increases the interaction
between the ligand and the divalent cations, particular for
Mg2+, and this eﬀect is observed in these calculations.
Table 2 showsthevaluesoftheinduceddipolemomentof
the ligands, obtained in the protein and water environments.
The largest induced dipole moment is observed for estradiol
boundinthepresenceofMg2+,whichhasavalueof3.8debye
relative to theinduced dipole moment of this ligand in water.
The similar increased induced dipole moment in the protein
with Mg2+ is also observed in these calculations for T4.
Although it is not systematically observed for all ligands,
there is a correlation between a value of the induced dipole
moment of the ligand and its interaction energy with the
surrounding environment that is caused by two eﬀects. The
ﬁrst is related to the change of the molecular geometry by
steric interactions between atoms of the ligand and atoms
of the active site pocket, or atoms of a ﬁrst solvation shell
of water. The second eﬀect is related to polarization of the
electronic density of the molecule by an electrostatic ﬁeld
of the protein or water surroundings. These calculations
show the second eﬀect is more important. The change of the
electronic density of the ligand inside the protein or water,
observed as an induced dipole moment, generates a stronger
attraction between polarized electrons of the ligand and the
electrostatic ﬁeld of the protein or water. As a consequence,
the stronger attraction increases the total interaction energy
between the ligand and the protein or water. The interaction
energiesshowastrongstabilizationeﬀectoftheboundligandJournal of Biomedicine and Biotechnology 9
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Figure 10: Stereoview of αvβ3 integrin RGD showing cis-resveratrol (green, Ca1), cis-resveratrol (yellow, Ca2), trans-resveratrol (beige,
Ca1), and trans-resveratrol (grey, Ca2) and the residues that make contact with the RGD site. The purple spheres are Mg2+ ions.
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Figure 11: Stereoview of αvβ3 integrin RGD showing cis-stilbene (gold, Ca1), cis-stilbene (cyan, Ca2), trans-stilbene (green, Ca1), and
trans-stilbene (purple, Ca2) and the residues that make contact with the RGD site.
to integrin. However, these QM/MM calculations do not
include polarization eﬀects of the protein or water by the
ligand that is inside these two environments. The QM/MM
calculations have been performed using an approach in
which all atoms of the protein or water are represented by
molecular mechanical atoms, and therefore they cannot be
polarized. Consequently, if polarization of the protein (or
water) is included in the QM/MM calculation, the calculated
interaction energy between the ligand and the surrounding
environments is expected to be even larger.
These studies reveal that there are two important eﬀects
responsible for the stabilization of the small molecules inside
the active site of integrin binding domain. The ﬁrst eﬀect
is related to internal ﬂexibility of the molecule which yields
better penetration of the molecule into the protein active
site, and consequently it increases its stabilization. The
second eﬀect is related to polarization of electronic density
of the molecule, by the electrostatic ﬁeld of the protein
(or water). Greater molecular polarization is responsible
for a larger induced dipole moment, which consequently
interacts more strongly with the surrounding protein (or
water) environments. Therefore, it can be ﬁnally concluded
that both molecular ﬂexibility and molecular polarizability
of the ligands are the main forces responsible for strength of
the binding process of the small molecules to αvβ3 integrin.
5. Conclusions
Recent data have shown that the hormone receptor on
αvβ3 integrin enables the thyroid hormones T4 and T310 Journal of Biomedicine and Biotechnology
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Figure 12: Stereoview of αvβ3 integrin RGD showing two orientations for estradiol (Ca2, (violet) and Ca2 (gold)).
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Figure 13: Stereoview of QM/MM model for T4 (cyan, Ca1), trans-resveratrol (yellow, Ca1), and RGD peptapeptide (violet) bound in αvβ3
integrin at the RGD binding site. The electrostatic surface for integrin is shown. Red is negative and blue is positive surface. αvd o m a i ni s
green and β3 domain is cyan. Figure drawn with PyMol.
to stimulate cancer cell proliferation and angiogenesis and
to regulate the activity of certain membrane pumps [28].
The results of these QM/MM modeling studies for a series
of thyroid or steroid-like ligands (Figure 2) bound to the
αvβ3 integrin reveal that these ligands have multiple modes
of binding near the RGD peptide binding site that was
shown to occupy a shallow crevice between the propeller
and βA domains of the integrin head [4]( Figure 1). The
most notable observation from these studies is that the
thyroid hormone analogues probe signiﬁcantly diﬀerent
conformational space near the RGD recognition site and that
these modes can be correlated with their biologic response to
signaling via the integrin. Furthermore, the binding modes
for T3 and T4ac are consistent with pharmacodynamic data
that indicate the presence of two discrete binding sites for
T3 that control distinct downstream signal transduction
pathways [28, 40]. Comparison of the low-energy binding
modes for thyroid hormones suggest that the positions of
T4 and T4ac illustrated in Figure 8 are consistent with data
that shows T4ac blocks T4 binding to integrin. The diﬀerent
binding positions of T3 (Figure 5) are also consistent with
data that suggest two discrete, but close, binding sites that
activate diﬀerent downstream signaling pathways [28].
The binding of resveratrol has been shown to interact
primarily with the β3 monomer of integrin, activating the
ERK1/2 pathway [18, 30]. These QM/MM modeling data for
cis- and trans-resveratrol indicate that both conformers have
intermolecular interactions with the side chain residues of
the β3 domain, although the cis-conformer which is ﬂipped
end to end with those of the transconformers can potentiallyJournal of Biomedicine and Biotechnology 11
be involved in more hydrogen bond interactions (Figure 10).
Furthermore, comparison of the binding of resveratrol with
T4 and T4ac (Figure 13) suggests a mechanism of ligand
recognition that is compatible with the observed down-
stream biological responses.
The QM/MM modeling data presented here show that
these ligands have ﬂexible binding modes and that some
ligands can bind in either a forward or reverse direction near
the RGD recognition site. This ﬂexibility in their low energy
conformations suggests that each ligand can selectively take
advantage of speciﬁc interactions within the local environ-
ment and with the metal binding sites. The observation of
multiple binding pockets near the RGD recognition site also
indicates that there may be subtle changes in the integrin
binding site that can dictate binding to alternate sites that
inﬂuence downstream signaling pathways.
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